Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS

By: via Benzinga
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it will receive milestone payments from Takeda Pharmaceutical Company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.